Inpatient Multimodal Intensive Care in Moderately Advanced Parkinson’s Disease: Role Of Medication Adjustment In Outcome Measures
Objective: In this study, we wish to determine whether medication changes play a major role in the improvements observed after in-patient multimodal intensive neurorehabilitation and…Impact of Over-the-counter Cannabidiol Products on Cognition During the Course of Parkinson’s Disease
Objective: To evaluate the association between Cannabidiol (CBD) usage and cognitive performance, measured by The Montreal Cognitive Assessment (MoCA) in people living with Parkinson's Disease…Isolation of Seeding Competent Material by Means of ThT Extraction
Objective: To develop a method for capturing α-synuclein (syn) seeds from cerebrospinal fluid (CSF) and other matrices with high affinity by means of thioflavin T…Monitoring Parkinson’s Disease in the Dental Chair
Objective: Our goal is to bridge the mechanistic knowledge gap on the Microbiota-Gut-Oral-Brain-Axis (MGOBA)’s role in Parkinson’s disease (PD) pathogenesis through a case-control, proof-of-concept, observational…Clinical Characteristics of Sporadic Parkinson’s Disease with Negative CSF Alpha-synuclein Seed Amplification Assay
Objective: Define clinical characteristics of individuals with sporadic Parkinson’s disease (sPD) enrolled in the Parkinson’s Progression Markers Initiative (PPMI) who have a negative CSF alpha-synuclein…Three Biopsies Optimizes Test Performance for the Detection of Cutaneous Phosphorylated Alpha-Synuclein
Objective: To review two independent data sets to define the test performance of skin biopsies for the detection of P-SYN and peripheral nerve degeneration in…Chronic DBS Stimulation’s effects after 1-hour off stimulation
Objective: This study investigates the changes in local field potential (LFP) activity during chronic deep brain stimulation (DBS) in patients with Parkinson's disease (PD) during…CSF Cadaverine and Other Polyamines as Biomarkers of Parkinson’s Disease: A PPMI Metabolomics Analysis
Objective: To identify novel biomarkers of Parkinson’s disease (PD) in Parkinson's Progression Markers Initiative (PPMI) cerebrospinal fluid (CSF) samples. Background: Altered polyamine levels in plasma…Auditory Musical Hallucinations in Parkinson’s disease: A Case Series
Objective: To report a series of twelve patients with Parkinson’s disease (PD) who experienced auditory musical hallucinations (AMH). Background: Hallucinations occur in 20-40% of patients…Effect of Systematic Survey-based Screening for Depression in Parkinson’s Disease
Objective: To determine the impact of systematic survey-based screening for depression on treatment outcomes in people with Parkinson's disease (PD) in a clinical practice setting. Background: Depression in…
- « Previous Page
- 1
- …
- 39
- 40
- 41
- 42
- 43
- …
- 181
- Next Page »